Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CXSL1900121	CBP-201注射液	rademikibart	Injection	Biological Products(1)	New Drug Application	2019-11-06	苏州康乃德生物医药有限公司	Suzhou Connect Biopharmaceuticals Ltd	In Review	2019-11-04	view
CXSB2000010	CBP-201注射液	rademikibart	Injection	Biological Products	Supplementary Application	2020-05-12	苏州康乃德生物医药有限公司	Suzhou Connect Biopharmaceuticals Ltd	In Review	2020-05-11	view
CXSL2000325	CBP-201注射液	rademikibart	Injection	Biological Products(1)	New Drug Application	2020-11-18	苏州康乃德生物医药有限公司	Suzhou Connect Biopharmaceuticals Ltd	In Review	2020-11-17	view
CXSL2100006	CBP-201注射液	rademikibart	Injection	Biological Products(1)	New Drug Application	2021-01-08	苏州康乃德生物医药有限公司	Suzhou Connect Biopharmaceuticals Ltd	In Review	2021-01-07	view
CXSB2300042	CBP-201注射液	rademikibart	Injection	Biological Products(1)	Supplementary Application	2023-04-22		Suzhou Connect Biopharmaceuticals Ltd			view
CXSB2300043	CBP-201注射液	rademikibart	Injection	Biological Products(1)	Supplementary Application	2023-04-22		Suzhou Connect Biopharmaceuticals Ltd			view
CXSB2400090	CBP-201注射液	rademikibart	Injection	Biological Products(1)	Supplementary Application	2024-08-29		Simcere Pharmaceutical Co Ltd			view
CXSB2400091	CBP-201注射液	rademikibart	Injection	Biological Products(1)	Supplementary Application	2024-08-29		Simcere Pharmaceutical Co Ltd			view